Search

Displaying results 3621 - 3630 of 7059 in total
  1. Drug

    Brodalumab

    go.drugbank.com/drugs/DB11776
    ApprovedInvestigational

    Brodalumab was FDA approved in February, 2017 as Siliq for the treatment of moderate-to-severe plaque psoriasis.

    Categories: Interleukin-17 Receptor A Antagonist, Interleukin 17 Receptor A Antagonists
  2. Drug

    Diiodohydroxyquinoline

    go.drugbank.com/drugs/DB09115
    Approved

    Iodoquinol is not currently available in any FDA-approved products. … Diiodohydroxyquinoline, also known as uidoquinol and iodoquinol, is a quinoline derivative that can be used in the treatment of amoebiasis. The exact mechanism of action is unknown.

    Mixtures: Alcortin A, Alcortin A
  3. Drug

    Panitumumab

    go.drugbank.com/drugs/DB01269
    ApprovedInvestigational

    Panitumumab was granted FDA approval on 27 September 2006.[L17663] … Panitumumab (ABX-EGF) is a recombinant human IgG2 monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). This drug is an antineoplastic agent.

  4. Drug

    Barucainide

    go.drugbank.com/drugs/DB19585
    Experimental

    Barucainide has a monoisotopic molecular weight of 354.23 Da. … Barucainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Barucainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  5. Drug

    Eptazocine

    go.drugbank.com/drugs/DB19670
    Experimental

    Eptazocine has a monoisotopic molecular weight of 231.16 Da. … Eptazocine is a small molecule drug. The usage of the INN stem '-azocine' in the name indicates that Eptazocine is a narcotic antagonist/agonist related to 6,7-benzomorphan.

  6. Drug

    Suricainide

    go.drugbank.com/drugs/DB19705
    Experimental

    Suricainide has a monoisotopic molecular weight of 369.21 Da. … Suricainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Suricainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  7. Drug

    Abitesartan

    go.drugbank.com/drugs/DB19863
    Experimental

    Abitesartan has a monoisotopic molecular weight of 461.24 Da. … Abitesartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Abitesartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).

  8. Drug

    Mindoperone

    go.drugbank.com/drugs/DB20001
    Experimental

    Mindoperone has a monoisotopic molecular weight of 408.22 Da. … Mindoperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Mindoperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  9. Drug

    Timiperone

    go.drugbank.com/drugs/DB20070
    Experimental

    Timiperone has a monoisotopic molecular weight of 397.16 Da. … Timiperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Timiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  10. Drug

    Mannomustine

    go.drugbank.com/drugs/DB20616
    Experimental

    Mannomustine has a monoisotopic molecular weight of 304.1 Da. … Mannomustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Mannomustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.